FDA Will Inspect Firms That Didn’t Participate In U.S.-Canada Program

Manufacturers that turned down FDA's offer to participate in its Pilot Multipurpose Audit Program (PMAP) will soon be inspected by the agency, CDRH's compliance chief says

More from Archive

More from Medtech Insight